# Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

> **NCT01527591** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 17 (actual)

## Conditions studied

- Infection in Solid Organ Transplant Recipients

## Interventions

- **BIOLOGICAL:** Pneumococcal Conjugate Vaccine 13 (PCV13)

## Key facts

- **NCT ID:** NCT01527591
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-02-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527591, "Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT01527591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*